Drug delivery systems for the treatment of sensorineural hearing loss

References

• Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 1997; 15: 631–43
   PubMed Web of Science ®Google Scholar
• Shinohara T, Bredberg G, Ulfendahl M, Pyykko I, Olivius NP, Kaksonen R, et al. Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci U S A 2002; 99: 1657–60
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Kim TS, Murai N, Endo T, Iguchi F, Tateya I, et al. A novel technique for inducing local inner ear damage. Hear Res 2003; 176: 122–7
   PubMed Web of Science ®Google Scholar
• Cunningham LL, Cheng AG, Rubel EW. Caspase activation in hair cells of the mouse utricle exposed to neomycin. J Neurosci 2002; 22: 8532–40
   PubMed Web of Science ®Google Scholar
• Duan ML, Ulfendahl M, Laurell G, Counter AS, Pyykko I, Borg E, et al. Protection and treatment of sensorineural hearing disorders caused by exogenous factors: experimental findings and potential clinical application. Hear Res 2002; 169: 169–78
   PubMed Web of Science ®Google Scholar
• Kawamoto K, Ishimoto S, Minoda R, Brough DE, Raphael Y. Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 2003; 23: 4395–400
   PubMed Web of Science ®Google Scholar
• Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, Dolan DF, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 2005; 11: 271–6
   PubMed Web of Science ®Google Scholar
• Maeda Y, Fukushima K, Nishizaki K, Smith RJ. In vitro and in vivo suppression of GJB2 expression by RNA interference. Hum Mol Genet 2005; 14: 1641–50
   PubMed Web of Science ®Google Scholar
• Juhn SK, Rybak LP. Labyrinthine barriers and cochlear homeostasis. Acta Otolaryngol (Stockh) 1981; 91: 529–34
   PubMed Web of Science ®Google Scholar
• Ersner MS. Transtympanic injection of anesthetics for the treatment of Menière's Syndrome. Arch Otorhinolaryngol 1951;43–52.
   Google Scholar
• Völger G. Beseitigung von Labyrinthliquordruckstörungen bei dem Menièrschen Symptomkomplex durch das Hyaluronidasepräparat Kinetin. HNO 1952; 3: 142–7
   Google Scholar
• Schuknecht HF. Ablation therapy for the relief of Meniere's disease. Laryngoscope 1956; 66: 859–70
   PubMedGoogle Scholar
• Salt AN, Plontke KR. Local inner-ear drug delivery and pharmacokinetics. Drug Discov Today 2005; 10: 1299–306
   PubMed Web of Science ®Google Scholar
• Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Meniere's disease. Laryngoscope 2004; 114: 102–5
   PubMed Web of Science ®Google Scholar
• Thomsen J, Charabi S, Tos M. Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease. Eur Arch Otorhinolaryngol 2000; 257: 362–5
   PubMed Web of Science ®Google Scholar
• Schoendorf J, Neugebauer P, Michel O. Continuous intratympanic infusion of gentamicin via a microcatheter in Meniere's disease. Otolaryngol Head Neck Surg 2001; 124: 203–7
   PubMedGoogle Scholar
• Yagi M, Magal E, Sheng Z, Ang KA, Raphael Y. Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Hum Gene Ther 1999; 10: 813–23
   PubMed Web of Science ®Google Scholar
• Staecker H, Li D, O'Malley BW, Jr, Van De Water TR. Gene expression in the mammalian cochlea: a study of multiple vector systems. Acta Otolaryngol (Stockh) 2001; 121: 157–63
   PubMed Web of Science ®Google Scholar
• Luebke AE, Foster PK, Muller CD, Peel AL. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer. Hum Gene Ther 2001; 12: 773–81
   PubMed Web of Science ®Google Scholar
• Nakaizumi T, Kawamoto K, Minoda R, Raphael Y. Adenovirus-mediated expression of brain-derived neurotrophic factor protects SGNs from ototoxic damage. Audiol Neurootol 2004; 9: 135–43
   PubMed Web of Science ®Google Scholar
• Hakuba N, Watabe K, Hyodo J, Ohashi T, Eto Y, Taniguchi M, et al. Adenovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cell loss after transient cochlear ischemia in gerbils. Gene Ther 2003; 10: 426–33
   PubMed Web of Science ®Google Scholar
• Ylikoski J, Pirvola U, Virkkala J, Suvanto P, Liang XQ, Magal E, et al. Guinea pig auditory neurons are protected by glial cell line-derived neurotrophic factor from degeneration after noise trauma. Hear Res 1998; 124: 17–26
   PubMed Web of Science ®Google Scholar
• Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol (Stockh) 2002; 122: 698–702
   PubMed Web of Science ®Google Scholar
• Paasche G, Gibson P, Averbeck T, Becker H, Lenarz T, Stover T. Technical report: modification of a cochlear implant electrode for drug delivery to the inner ear. Otol Neurotol 2003; 24: 222–7
   PubMed Web of Science ®Google Scholar
• Kushibiki T, Matsumoto K, Nakamura T, Tabata Y. Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin. Gene Ther 2004; 11: 1205–14
   PubMed Web of Science ®Google Scholar
• Arnold W, Senn P, Hennig M, Michaelis C, Deingruber K, Scheler R, et al. Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigs. Audiol Neurotol 2005; 10: 53–63
   PubMed Web of Science ®Google Scholar
• Tamura T, Kita T, Nakagawa T, Endo T, Kim TS, Ishihara T, et al. Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope 2005; 115: 2000–5
   PubMed Web of Science ®Google Scholar
• Endo T, Nakagawa T, Kita T, Iguchi F, Kim TS, Tamura T, et al. A novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005; 115: 2016–20
   PubMed Web of Science ®Google Scholar
• Iwai K, Nakagawa T, Endo T, Matsuoka Y, Kita T, Kim TS, et al. Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel. Laryngoscope 2006; 116: 529–33
   PubMed Web of Science ®Google Scholar
• Colas A. Silicones in pharmaceutical applications. DowCorning Healthcare Industries. http://www.dowcorning.com/content/publishedlit/51-993a-01.pdf.
   Google Scholar
• Ishihara T, Izumo N, Higaki M, Shimada E, Hagi T, Mine L, et al. Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile. J Control Release 2005; 105: 68–76
   PubMed Web of Science ®Google Scholar
• Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005; 109: 256–74
   PubMed Web of Science ®Google Scholar
• Okada H, Yamamoto M, Heya Y, Inoue Y, Kamei S, Ogawa Y, et al. Drug delivery using biodegradable microspheres. J Control Release 1994; 28: 121–9
   Web of Science ®Google Scholar
• Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. Preparation of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Control Release 1993; 25: 89–98
   Web of Science ®Google Scholar
• Higaki M, Ishihara T, Izumo N, Takatsu M, Mizushima Y. Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate. Ann Rheum Dis 2005; 64: 1132–6
   PubMed Web of Science ®Google Scholar
• Sakai T, Kohno H, Ishihara T, Higaki M, Saito S, Matsushima M, et al. Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate. Exp Eye Res 2006; 82: 657–63
   PubMed Web of Science ®Google Scholar
• Husmann KR, Morgan AS, Girod DA, Durham D. Round window administration of gentamicin: a new method for the study of ototoxicity of cochlear hair cells. Hear Res 1998; 125: 109–19
   PubMed Web of Science ®Google Scholar
• Hatano T, Miyamoto S, Kawakami O, Yamada K, Hashimoto N, Tabata Y. Acceleration of aneurysm healing by controlled release of basic fibroblast growth factor with the use of polyethylene terephthalate fiber coils coated with gelatin hydrogel. Neurosurgery 2003; 53: 393–400
   PubMed Web of Science ®Google Scholar
• Park H, Temenoff JS, Holland TA, Tabata Y, Mikos AG. Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 2005; 26: 7095–103
   PubMed Web of Science ®Google Scholar
• Alzamil KS, Linthicum FH, Jr. Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Ann Otol Rhinol Laryngol 2000; 109: 30–2
   PubMed Web of Science ®Google Scholar